“Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia sissoo: In Silico Prediction in Antidiabetic Potential”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 5, pp. 841–854, Sep. 2024, doi: 10.25004/IJPSDR.2024.160512.